Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' (Deficit) Equity

v3.10.0.1
Consolidated Statements of Changes in Stockholders' (Deficit) Equity - USD ($)
Total
ProstaGene, LLC
Preferred Stock
Common Stock
Common Stock
ProstaGene, LLC
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
ProstaGene, LLC
Accumulated Deficit
Beginning balance (Fiscal Year To Date) at May. 31, 2017 $ (1,103,234)                
Beginning balance at May. 31, 2017 (1,103,234)   $ 92 $ 149,468     $ 121,736,921   $ (122,989,715)
Beginning balance, shares at May. 31, 2017     92,100 149,468,244          
Proceeds from warrant exercise | Fiscal Year To Date 1,647,500                
Proceeds from warrant exercise 1,647,500     $ 3,295     1,644,205    
Proceeds from warrant exercise, shares       3,295,000          
Offering costs related to registered direct offering, shares     0 0   0      
Interest expense related to warrant extension | Fiscal Year To Date 826,252                
Interest expense related to warrant extension 826,252           826,252    
Debt discount related to convertible notes payable | Fiscal Year To Date 1,645,010                
Debt discount related to convertible notes payable 1,645,010           1,645,010    
Stock-based compensation | Fiscal Year To Date 254,952                
Stock-based compensation 254,952           254,952    
Net loss | Fiscal Year To Date (11,628,273)                
Net loss (11,628,273)               (11,628,273)
Ending balance (Fiscal Year To Date) at Aug. 31, 2017 (8,357,793)                
Ending balance at Aug. 31, 2017 (8,357,793)   $ 92 $ 152,763     126,107,340   (134,617,988)
Ending balance, shares at Aug. 31, 2017     92,100 152,763,244          
Beginning balance (Fiscal Year To Date) at May. 31, 2017 (1,103,234)                
Beginning balance at May. 31, 2017 (1,103,234)   $ 92 $ 149,468     121,736,921   (122,989,715)
Beginning balance, shares at May. 31, 2017     92,100 149,468,244          
Net loss (22,575,959)                
Ending balance (Fiscal Year To Date) at Nov. 30, 2017 (12,790,510)                
Ending balance at Nov. 30, 2017 (12,790,510)   $ 92 $ 165,135     132,609,936   (145,565,673)
Ending balance, shares at Nov. 30, 2017     92,100 165,135,155          
Beginning balance (Fiscal Year To Date) at Aug. 31, 2017 (8,357,793)                
Beginning balance at Aug. 31, 2017 (8,357,793)   $ 92 $ 152,763     126,107,340   (134,617,988)
Beginning balance, shares at Aug. 31, 2017     92,100 152,763,244          
Proceeds from warrant exercise | Fiscal Year To Date 1,647,500                
Proceeds from private equity offering, value | Fiscal Year To Date 3,325,397                
Proceeds from private equity offering, value 3,325,397     $ 6,652     3,318,745    
Offering costs related to private equity offering | Fiscal Year To Date (312,456)                
Offering costs related to private equity offering (312,456)           (312,456)    
Proceeds from private equity offering, shares       6,651,800          
Offering costs related to registered direct offering | Fiscal Year To Date (319,228)                
Offering costs related to registered direct offering (319,228)           (319,228)    
Proceeds from registered direct offering, shares       5,720,111          
Proceeds from registered direct offering | Fiscal Year To Date 3,725,254                
Proceeds from registered direct offering 3,725,254     $ 5,720     3,719,534    
Offering costs related to registered direct offering, shares     0 0   0      
Legal fees in connection with equity offerings | Fiscal Year To Date (178,664)                
Legal fees in connection with equity offerings (178,664)           (178,664)    
Interest expense related to warrant extension | Fiscal Year To Date 826,252                
Debt discount related to convertible notes payable | Fiscal Year To Date 1,645,010                
Stock-based compensation | Fiscal Year To Date 529,617                
Stock-based compensation 274,665           274,665    
Net loss | Fiscal Year To Date (22,575,958)                
Net loss (10,947,685)               (10,947,685)
Ending balance (Fiscal Year To Date) at Nov. 30, 2017 (12,790,510)                
Ending balance at Nov. 30, 2017 (12,790,510)   $ 92 $ 165,135     132,609,936   (145,565,673)
Ending balance, shares at Nov. 30, 2017     92,100 165,135,155          
Proceeds from warrant exercise | Fiscal Year To Date 1,647,500                
Proceeds from private equity offering, value | Fiscal Year To Date 17,642,948                
Proceeds from private equity offering, value 14,317,551     $ 28,635     14,288,916    
Offering costs related to private equity offering | Fiscal Year To Date (1,729,242)                
Offering costs related to private equity offering (1,416,786)           (1,416,786)    
Proceeds from private equity offering, shares       28,635,104          
Offering costs related to registered direct offering | Fiscal Year To Date (650,849)                
Offering costs related to registered direct offering (331,621)           (331,621)    
Proceeds from registered direct offering, shares       15,133,742          
Proceeds from registered direct offering | Fiscal Year To Date 11,291,419                
Proceeds from registered direct offering 7,566,165     $ 15,134     7,551,031    
Offering costs related to registered direct offering, shares     0 0   0      
Interest expense related to warrant tender offer | Fiscal Year To Date 2,352,045                
Interest expense related to warrant tender offer 2,352,045           2,352,045    
Legal fees in connection with equity offerings | Fiscal Year To Date (344,886)                
Legal fees in connection with equity offerings (166,222)           (166,222)    
Stock issued for board compensation | Fiscal Year To Date 260,190                
Stock issued for board compensation 260,190           260,190    
Interest expense related to warrant extension | Fiscal Year To Date 826,252                
Debt discount related to convertible notes payable | Fiscal Year To Date 1,645,010                
Stock-based compensation | Fiscal Year To Date 1,096,226                
Stock-based compensation 566,609           566,609    
Net loss | Fiscal Year To Date (40,526,058)                
Net loss (17,950,100)               (17,950,100)
Ending balance (Fiscal Year To Date) at Feb. 28, 2018 (7,592,679)                
Ending balance at Feb. 28, 2018 (7,592,679)   $ 92 $ 208,904     155,714,098   (163,515,773)
Ending balance, shares at Feb. 28, 2018     92,100 208,904,001          
Proceeds from warrant exercise | Fiscal Year To Date 3,161,131                
Proceeds from warrant exercise 1,513,631     $ 3,027     1,510,604    
Proceeds from warrant exercise, shares       3,027,263          
Offering costs related to warrant tender offer | Fiscal Year To Date (73,234)                
Offering costs related to warrant tender offer (73,234)           (73,234)    
Proceeds from private equity offering, value | Fiscal Year To Date 17,642,948                
Offering costs related to private equity offering | Fiscal Year To Date (1,729,242)                
Offering costs related to registered direct offering | Fiscal Year To Date (857,149)                
Offering costs related to registered direct offering (206,300)           (206,300)    
Interest expense related to conversion of notes payable | Fiscal Year To Date 393,686                
Interest expense related to conversion of notes payable 393,686           393,686    
Proceeds from registered direct offering, shares       4,640,000          
Proceeds from registered direct offering | Fiscal Year To Date 13,611,419                
Proceeds from registered direct offering 2,320,000     $ 4,640     2,315,360    
Offering costs related to registered direct offering, shares     0 0   0      
Stock issued for bonuses and tendered for income tax, shares       310,526   159,011      
Interest expense related to warrant tender offer | Fiscal Year To Date 2,352,045                
Stock issued for bonuses and tendered for income tax, value | Fiscal Year To Date 104,545                
Stock issued for bonuses and tendered for income tax, value 104,545     $ 310   $ (159) 104,394    
Legal fees in connection with equity offerings | Fiscal Year To Date (533,434)                
Legal fees in connection with equity offerings (188,548)           (188,548)    
Stock issued for board compensation | Fiscal Year To Date 260,190                
Interest expense related to warrant extension | Fiscal Year To Date 826,252                
Debt discount related to convertible notes payable | Fiscal Year To Date 1,645,010                
Stock-based compensation | Fiscal Year To Date 1,290,777                
Stock-based compensation 194,551           194,551    
Net loss | Fiscal Year To Date (50,149,681)                
Net loss (9,623,623)               (9,623,623)
Ending balance (Fiscal Year To Date) at May. 31, 2018 (13,157,971)                
Ending balance at May. 31, 2018 (13,157,971)   $ 92 $ 216,881   $ (159) 159,764,611   (173,139,396)
Ending balance, shares at May. 31, 2018     92,100 216,881,790   159,011      
Proceeds from private equity offering, value | Fiscal Year To Date 7,514,300                
Proceeds from private equity offering, value 7,514,300     $ 15,029     7,499,271    
Proceeds from private equity offering, shares       15,028,600          
Offering costs related to private equity offering | Fiscal Year To Date (882,716)                
Offering costs related to private equity offering (882,716)           (882,716)    
Proceeds from registered direct offering, shares       1,970,000          
Proceeds from registered direct offering | Fiscal Year To Date 985,000                
Proceeds from registered direct offering 985,000     $ 1,970     983,030    
Offering costs related to registered direct offering | Fiscal Year To Date (75,151)                
Offering costs related to registered direct offering (75,151)           (75,151)    
Offering costs related to registered direct offering, shares     0 0   0      
Legal fees in connection with equity offerings | Fiscal Year To Date (50,544)                
Legal fees in connection with equity offerings (50,544)           (50,544)    
Stock-based compensation | Fiscal Year To Date 283,346                
Stock-based compensation 283,346           283,346    
Net loss | Fiscal Year To Date (14,413,569)                
Net loss (14,413,569)               (14,413,569)
Ending balance (Fiscal Year To Date) at Aug. 31, 2018 (19,797,305)                
Ending balance at Aug. 31, 2018 (19,797,305)   $ 92 $ 233,880   $ (159) 167,521,847   (187,552,965)
Ending balance, shares at Aug. 31, 2018     92,100 233,880,390   159,011      
Beginning balance (Fiscal Year To Date) at May. 31, 2018 (13,157,971)                
Beginning balance at May. 31, 2018 (13,157,971)   $ 92 $ 216,881   $ (159) 159,764,611   (173,139,396)
Beginning balance, shares at May. 31, 2018     92,100 216,881,790   159,011      
Acquisition   $ 11,558,000              
Net loss (28,718,950)                
Ending balance (Fiscal Year To Date) at Nov. 30, 2018 (8,063,924)                
Ending balance at Nov. 30, 2018 (8,063,924)   $ 92 $ 290,810   $ (159) 193,503,678   (201,858,345)
Ending balance, shares at Nov. 30, 2018     92,100 290,808,960   159,011      
Beginning balance (Fiscal Year To Date) at Aug. 31, 2018 (19,797,305)                
Beginning balance at Aug. 31, 2018 (19,797,305)   $ 92 $ 233,880   $ (159) 167,521,847   (187,552,965)
Beginning balance, shares at Aug. 31, 2018     92,100 233,880,390   159,011      
Acquisition | Fiscal Year To Date   11,558,000              
Acquisition   $ 11,558,000     $ 18,658     $ 11,539,342  
Acquisition, share         18,658,000        
Issuance of stock payment shares | Fiscal Year To Date 8,342                
Issuance of stock payment shares 8,342     $ 8,342          
Proceeds from private equity offering, value | Fiscal Year To Date 22,478,585                
Proceeds from private equity offering, value 14,964,285     $ 29,930     14,934,355    
Issuance of stock payment shares, shares       8,342,000          
Proceeds from private equity offering, shares       29,928,570          
Offering costs related to private equity offering | Fiscal Year To Date (2,576,070)                
Offering costs related to private equity offering (1,693,354)           (1,693,354)    
Proceeds from registered direct offering | Fiscal Year To Date 985,000                
Offering costs related to registered direct offering | Fiscal Year To Date (75,151)                
Offering costs related to registered direct offering, shares     0 0   0      
Legal fees in connection with equity offerings | Fiscal Year To Date (76,195)                
Legal fees in connection with equity offerings (25,652)           (25,652)    
Stock-based compensation | Fiscal Year To Date 1,510,486                
Stock-based compensation 1,227,140           1,227,140    
Net loss | Fiscal Year To Date (28,718,950)                
Net loss (14,305,380)               (14,305,380)
Ending balance (Fiscal Year To Date) at Nov. 30, 2018 (8,063,924)                
Ending balance at Nov. 30, 2018 $ (8,063,924)   $ 92 $ 290,810   $ (159) $ 193,503,678   $ (201,858,345)
Ending balance, shares at Nov. 30, 2018     92,100 290,808,960   159,011